Middle-ear dexamethasone delivery via ultrasound microbubbles attenuates noise-induced hearing loss.
Animals
Anti-Inflammatory Agents
/ administration & dosage
Cochlea
/ drug effects
Dexamethasone
/ administration & dosage
Disease Models, Animal
Drug Delivery Systems
Guinea Pigs
HMGB1 Protein
/ metabolism
Hearing Loss, Noise-Induced
/ drug therapy
Male
Microbubbles
Protective Factors
Round Window, Ear
Ultrasonography
Round window membrane
dexamethasone
drug delivery
hearing loss
intratympanic injection
microbubble
noise exposure
ultrasound
Journal
The Laryngoscope
ISSN: 1531-4995
Titre abrégé: Laryngoscope
Pays: United States
ID NLM: 8607378
Informations de publication
Date de publication:
08 2019
08 2019
Historique:
accepted:
31
10
2018
pubmed:
28
12
2018
medline:
21
8
2019
entrez:
28
12
2018
Statut:
ppublish
Résumé
In this study, we expanded our previous investigation by testing the efficiency of trans-round window membrane dexamethasone (DEX) delivery mediated by ultrasound (US)-aided microbubbles (MBs) and its preventive effects regarding noise exposure in animal models. Live animal model. Forty-two pigmented male guinea pigs were divided into the following three groups: an US-MBs (USM) group, in which the tympanic bulla was filled with DEX and MBs and exposed to US; a round window soaking (RWS) group, without the US irradiation; and a control group. The above-mentioned manipulations were performed 2 hours prior to white noise exposure. The cochlear damage, including auditory threshold shifts, hair cell loss, and expression of cochlear HMGB1, was evaluated. The enhanced DEX delivery efficiency of the USM group was approximately 2.4× to 11.2× greater than that of the RWS group. After the noise exposure, the RWS group showed significant cochlear protection compared with the control group, and more significant and dominant protective effects were demonstrated in the USM group. The application of US-MBs provides a safe and more effective approach than spontaneous diffusion, which is commonly used in clinical practice; thus, this technique holds potential for future inner-ear drug delivery. NA Laryngoscope, 129:1907-1914, 2019.
Substances chimiques
Anti-Inflammatory Agents
0
HMGB1 Protein
0
Dexamethasone
7S5I7G3JQL
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Pagination
1907-1914Informations de copyright
© 2018 The American Laryngological, Rhinological and Otological Society, Inc.